Clinical Trial

Oophorectomy, Estrogen Therapy and Cardiovascular Risk

Study Description

Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women

Researchers are trying to assess the appropriate dose of estrogen for decreasing the risk of cardiovascular disease in women who have removal of their ovaries at a young age, before the age of 46 years.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Estradiol 100 Micrograms Patch

Standard

Drug - Estradiol Patch

Individualized

Additional Information

Official Study Title

Impact of Individualized Estrogen Therapy on Cardiovascular Disease Risk Parameters in Young Women After Bilateral Oophorectomy: A Randomized Controlled Trial

Clinical Trial ID

NCT03815929

ParticipAid ID

dwp7me